Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orthomimetics developed collagen-based, multi-layer porous scaffold implants for regenerative repair of osteochondral, meniscal, ligament and tendon lesions; its lead product ChondroMimetic obtained CE Mark in 2008 and was used clinically in over 300 procedures in Europe and other territories with positive large-animal and early human data before commercialization was later deprioritized by its acquirers.[1][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orthomimetics.